Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Gastrointestinal 44Breast 41Genitourinary 33Other hematologic neoplasm 28Tumor-Agnostic 27Gynecologic 26Other solid neoplasm 25Thoracic 21Head & Neck 17Lymphoid 16Plasma cell 8Other 7Sarcoma 6Dermatologic 6CNS 6Other neoplasm 4Myeloid 4Endocrine 3Classical hematology 1

Conditions

Melanoma 4Uveal Melanoma 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Spondylitis, Ankylosing 1Psoriasis 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Identification of Skin Cancer Biopsy Sites 1Crohn Disease 1Communication 1Colitis, Ulcerative 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interviews as Topic × Dermatologic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT06073548 2023-10-10

SALOME Quali

Institut Curie

Unknown
250 enrolled
Dermatologic

Uveal Melanoma, Communication

NCT01632644 2021-12-06

Identifying Skin Biopsy Sites

Northwestern University

Completed
59 enrolled
Dermatologic

Identification of Skin Cancer Biopsy Sites

NCT00510302 2020-09-16

Melanoma Risk-Reduction Among Patients and Family Members

M.D. Anderson Cancer Center

Completed
170 enrolled
Dermatologic

Melanoma

NCT00394134 2019-09-13

Targeted Intervention for Melanoma Prevention

M.D. Anderson Cancer Center

Phase NA Completed
205 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡